Experimental Lung Inflammation
|
disease |
Infections; Respiratory Tract Diseases
|
Experimental Model of Disease
|
54
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Pneumonia
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
1032
|
33
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lobar Pneumonia
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
140
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
90
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pulpitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
47
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Interleukin 1 Receptor-Like 1 Measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
751
|
232
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Nephropathia Epidemica
|
disease |
Infections
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Osteoarthritis of the hand
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
61
|
21
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.010 |
None |
< 0.001 |
1 |
3
|
2012 |
2012 |
Invasive Pulmonary Aspergillosis
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
42
|
3
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adult Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
62
|
2
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
509
|
12
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Childhood Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
140
|
1
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Childhood Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
62
|
2
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Prolapsed lumbar disc
|
disease |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Acquired Abnormality
|
75
|
33
|
0.010 |
None |
1.000 |
1 |
2
|
2019 |
2019 |